Illumina MiniSeq Sequencer Molecular Biology DNA Sequencing Lab Equipment
Illumina
Details
-
CategoryMolecular Biology
-
Dimension19.0in x 20.0in x 21.0in
-
SerialMN00447
-
Shipping TypeFedEx Ground
-
ManufacturingDoes Not Apply
-
Voltage / HertzDoes Not Apply / Does Not Apply
Description
The Illumina MiniSeq Sequencer, manufactured by Illumina, is designed for efficient DNA sequencing applications, delivering high throughput in a compact format. Though unable to be fully tested, this unit powers on and completes basic tests without reporting functional issues, and is rated in good condition. Ideal for laboratories focused on genomic research, the MiniSeq offers a versatile platform for various sequencing projects. This unit has cosmetic signs of wear, typical of previous use, originating from the United States. Power, computer, or software accessories are not included. With its robust configurations, the MiniSeq enhances sequencing throughput essential for advanced molecular biology research.
Key Features
- Compact design with high throughput capabilities
- Suitable for various DNA sequencing applications
- Good condition with operational checks passed
- Manufactured by Illumina, a leader in genomic technology
- Sturdy build with typical wear from prior use
Specifications
- Throughput: Optimal for small to mid-scale sequencing projects
- Applications: Common in research and clinical labs for DNA analysis
- Condition Class: G (Good) - Fully operational from power-on and basic tests
- Configuration: Basic unit without included peripherals
- Country of Origin: United States
- Known Issues: Cosmetic wear without functionality concerns
Weight
Imperial: 150.0 Pounds
Metric: 68.04 Kilograms
Shipping Dimensions
Imperial: 22.8 lb x 24.0 lb x 25.2 lb
Metric: 57.91 cm x 60.96 cm x 64.01 cm
Harmonized Code
9027.50
Harmonized Code Details
9027.50 - Instruments and apparatus for physical or chemical analysis. This code is applicable as it includes tools used for DNA sequencing, which fall within chemical analysis categories.
Comments 0
There are currently no public comments.